Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis

NCT07181811 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

FED

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: Multiple Sclerosis patients who have been on Ocrelizumab will undergo cognitive and fatigue assessments

Sponsor

Anza Memon

Collaborators

[object Object]